10 lectures · 63 items
11 min
9 min
6 min
16 min
37 min
30 min
37 min
18 min
10 min
7 min
EPCCS refreshes identity to champion integrated Cardiorenalmetabolic Care in Primary Care
Introducing GPcardio: Bridging the Gap in Cardiovascular Care
Enhanced remote medication program boosts GDMT prescriptions for high CV or kidney risk in T2D patients
EPCCS Symposium held at WONCA Europe 2026 on Cardio Renal Metabolic Disease
Cardio Renal Update
WONCA World 2025
CVD, CKD & T2D
About EPCCSEpidemiology, current clinical implications and future burden.
The cardiovascular-kidney-metabolic (CKM) syndrome framework captures the continuum linking obesity, metabolic dysfunction, chronic kidney disease, and cardiovascular disease. Population data show…
international target trial emulation.
An international target trial emulation involving 64,036 patients on dialysis demonstrates that deceased donor kidney transplantation using standard criteria donors (SCD) significantly improves…
balancing euglycaemic ketoacidosis risk and cardiorenal benefits.
This review addresses the perioperative management of SGLT2 inhibitors in patients with heart failure, chronic kidney disease, or type 2 diabetes. While guidelines typically recommend withholding the…
A Scientific Statement From the American Heart Association.
The American Heart Association has released a scientific statement highlighting sex-specific differences in chronic kidney disease (CKD), emphasizing biological factors, underrepresentation in…
a systematic review.
A systematic review of pooled analyses from the FIDELITY programme demonstrates that finerenone significantly reduces composite renal and cardiovascular outcomes in patients with diabetic kidney…
the CREDENCE trial.
A post-hoc analysis of the CREDENCE trial found that canagliflozin maintains consistent efficacy and safety across varying levels of polypharmacy in patients with type 2 diabetes and chronic kidney…
Chronic kidney disease is driven by a pro-inflammatory state that accelerates both renal decline and major cardiovascular events. This review outlines key inflammatory pathways and highlights…
lifelong connections.
A narrative review in the European Heart Journal highlights that adverse pregnancy outcomes, including hypertensive disorders, gestational diabetes, and preterm birth, serve as early markers of…
a multicentre cross-sectional study.
A multicentre cross-sectional study of 15,879 adults in the UK compared five creatinine-based eGFR equations against measured GFR. The Lund-Malmö Revised (LMR) and EKFC equations demonstrated the…
In a large retrospective target trial emulation using electronic health records, initiation of GLP-1 receptor agonists versus SGLT2 inhibitors was associated with significantly lower 4-year all-cause…
eGFR and albuminuria for every cardiac patient, an SGLT2 inhibitor regardless of ejection fraction, and a chair from Groningen
Published today in the European Heart Journal ahead of its Saturday presentation: the first ESC guideline that treats cardiovascular disease and chronic kidney disease as one condition, endorsed by…
Translating Evidence into Clinical Practice.
Chronic kidney disease in type 2 diabetes affects 30–40% of patients and substantially increases cardiovascular risk and mortality. Recent evidence supports the simultaneous use of SGLT2 inhibitors…